FDA Inspection 1061620 — Richard Joseph Schmidt, MD, Inc.
The FDA completed an inspection of Richard Joseph Schmidt, MD, Inc. on Jul 20, 2018 in Mountain View, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Mountain View, CA (United States)